Bridget F. Kilbride, BS

Research and Development Engineer
University of California, San Francisco, United States

Presentation(s):

• Comparing Demographic Factors and Outcomes in Hepatocellular Carcinoma Treatment: Evaluation of Y90 Radioembolization versus Combined TACE plus MWA

  Monday, March 31, 2025
  3:00 PM – 3:09 PM CT